CD44 and bronchiectasis: A previous study presented by Owen and co-workers [9], [10] showed that HLE binds to soluble high Mr heparan sulfate proteoglycans (HSPG) shed into bronchial secretions from patients with bronchiectasis and into acute human dermal wound fluids [8], [11], retaining its catalytic activity against extracellular matrix substrates.